Study on the construction of defense system of Qiantang River estuary seawall project in the new eraYanfen Yu, Linjie Wang, Mei Chen et al.|Unknown|2022Cited by 0
Vispa-Cel, an Allogeneic Anti-CD19 CAR-T cell Therapy with a PD-1 Knockout, In Patients with relapsed/refractory B cell Non-Hodgkin Lymphoma (r/r B-NHL): Updated Results from the Antler Phase 1 Clinical TrialMehdi Hamadani, Susan O'Brien, Houston Holmes et al.|Transplantation and Cellular Therapy|2026Cited by 0